CL2008000138A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM 19-NORPREGNANO; AND ITS USE AS AN CONTRACEPTIVE. - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM 19-NORPREGNANO; AND ITS USE AS AN CONTRACEPTIVE.

Info

Publication number
CL2008000138A1
CL2008000138A1 CL200800138A CL2008000138A CL2008000138A1 CL 2008000138 A1 CL2008000138 A1 CL 2008000138A1 CL 200800138 A CL200800138 A CL 200800138A CL 2008000138 A CL2008000138 A CL 2008000138A CL 2008000138 A1 CL2008000138 A1 CL 2008000138A1
Authority
CL
Chile
Prior art keywords
norpregnano
contraceptive
pharmaceutical composition
compound derived
derived
Prior art date
Application number
CL200800138A
Other languages
Spanish (es)
Inventor
Joseph Podolski
Original Assignee
Repros Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repros Therapeutics Inc filed Critical Repros Therapeutics Inc
Publication of CL2008000138A1 publication Critical patent/CL2008000138A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL200800138A 2007-01-17 2008-01-17 PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM 19-NORPREGNANO; AND ITS USE AS AN CONTRACEPTIVE. CL2008000138A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88536307P 2007-01-17 2007-01-17

Publications (1)

Publication Number Publication Date
CL2008000138A1 true CL2008000138A1 (en) 2008-05-16

Family

ID=39387140

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800138A CL2008000138A1 (en) 2007-01-17 2008-01-17 PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM 19-NORPREGNANO; AND ITS USE AS AN CONTRACEPTIVE.

Country Status (16)

Country Link
EP (1) EP2125858A2 (en)
JP (1) JP2010516686A (en)
KR (1) KR20090105944A (en)
CN (1) CN101616926A (en)
AR (1) AR064947A1 (en)
AU (1) AU2008206599A1 (en)
BR (1) BRPI0806572A2 (en)
CA (1) CA2674440A1 (en)
CL (1) CL2008000138A1 (en)
CR (1) CR10924A (en)
EA (1) EA200970692A1 (en)
EC (1) ECSP099537A (en)
IL (1) IL199684A0 (en)
MX (1) MX2009007313A (en)
TW (1) TW200835503A (en)
WO (1) WO2008088935A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI477276B (en) * 2008-04-28 2015-03-21 Repros Therapeutics Inc Antiprogestin dosing regimens
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
HUP0900171A2 (en) 2009-03-20 2010-12-28 Richter Gedeon Nyrt Novel crystal form of 17-acetoxy-11›-[4-(dimethyl-amino)-phenyl]-21-metoxy-19-norpregna-4,9-dien-3,20-dione and process for it's preparation
HUP0900487A2 (en) * 2009-08-05 2011-03-28 Richter Gedeon Nyrt Novel crystal polymorphic form of 17-acetoxy-11 -[4-(dimethylamino)phenyl]-21-methoxy-4,9-diene-3,20-dione and process for it's preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US8044223B2 (en) * 2003-04-04 2011-10-25 Bridge Organics Co. Crystalline 19-norsteroids

Also Published As

Publication number Publication date
MX2009007313A (en) 2009-07-15
AR064947A1 (en) 2009-05-06
JP2010516686A (en) 2010-05-20
WO2008088935A2 (en) 2008-07-24
ECSP099537A (en) 2009-08-28
IL199684A0 (en) 2010-04-15
WO2008088935A3 (en) 2009-03-05
CA2674440A1 (en) 2008-07-24
BRPI0806572A2 (en) 2014-05-06
AU2008206599A1 (en) 2008-07-24
EA200970692A1 (en) 2010-02-26
KR20090105944A (en) 2009-10-07
CN101616926A (en) 2009-12-30
TW200835503A (en) 2008-09-01
EP2125858A2 (en) 2009-12-02
CR10924A (en) 2009-10-30

Similar Documents

Publication Publication Date Title
CL2007003470A1 (en) UREA DERIVATIVE COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE AS ANTIBACTERIALS.
BRPI0815709A2 (en) composition, pharmaceutical composition, and use of a compound.
BRPI1007018A2 (en) compound, pharmaceutical composition, and use of a compound.
BRPI1008906A2 (en) compound, pharmaceutical composition, and use of a compound.
BRPI0716171A2 (en) compound, pharmaceutical composition and use of a compound.
CL2007002377A1 (en) COMPOUNDS DERIVED FROM QUINAZOLINA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE AS ANTICANCERIGENO.
BRPI0810696A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND
BRPI0919942A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND
BRPI0907562A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI0921375A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI0814593A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
BR112012004335A2 (en) compound, pharmaceutical composition, and use of the compound.
BRPI1016219A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI1008793A2 (en) compound use of a compound and pharmaceutical composition
CL2007002916A1 (en) COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS.
BRPI0921879A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI1009757A2 (en) compound, pharmaceutical composition, and use of a compound.
BRPI0810019A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND
BRPI0906937A2 (en) compound, pharmaceutical composition, and use of a compound
BRPI0812942A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND
CL2007001919A1 (en) COMPOUNDS DERIVED FROM 18-METIL-15B, 16B-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS, USEFUL AS CONTRACEPTIVE.
HN2008001723A (en) SIPROCICLIC NITRILS AS PROTEASA INHIBITORS
ES2465478T8 (en) Pharmaceutical compositions comprising brivaracetam
BRPI0810399A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USING THEREOF
BRPI0716698A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION AND USE OF A COMPOUND